These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25248313)

  • 1. Faecal gas analysis by electronic nose as novel, non-invasive method for assessment of active and quiescent paediatric inflammatory bowel disease: Proof of principle study.
    de Meij TG; de Boer NK; Benninga MA; Lentferink YE; de Groot EF; van de Velde ME; van Bodegraven AA; van der Schee MP
    J Crohns Colitis; 2014 Sep; ():. PubMed ID: 25248313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal Volatile Organic Compound Analysis in De Novo Paediatric Inflammatory Bowel Disease by Gas Chromatography-Ion Mobility Spectrometry: A Case-Control Study.
    Vermeer E; Jagt JZ; Stewart TK; Covington JA; Struys EA; de Jonge R; de Boer NKH; de Meij TGJ
    Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.
    Belnour S; Slater R; Tharmaratnam K; Karl-Heinz Auth M; Muhammed R; Spray C; Wang D; Zeeshan Ijaz U; Probert C; Allen S
    United European Gastroenterol J; 2024 Jul; 12(6):780-792. PubMed ID: 38922802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis.
    Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH
    Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
    Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
    Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
    Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
    Boon GJ; Day AS; Mulder CJ; Gearry RB
    World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease.
    Vitali R; Palone F; Armuzzi A; Fulci V; Negroni A; Carissimi C; Cucchiara S; Stronati L
    J Crohns Colitis; 2023 Jan; 17(1):92-102. PubMed ID: 36040453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.
    Ahmed I; Greenwood R; Costello B; Ratcliffe N; Probert CS
    Aliment Pharmacol Ther; 2016 Mar; 43(5):596-611. PubMed ID: 26806034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
    Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
    Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis.
    Smolinska A; Bodelier AG; Dallinga JW; Masclee AA; Jonkers DM; van Schooten FJ; Pierik MJ
    Aliment Pharmacol Ther; 2017 May; 45(9):1244-1254. PubMed ID: 28239876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease.
    Kolho KL; Pessia A; Jaakkola T; de Vos WM; Velagapudi V
    J Crohns Colitis; 2017 Mar; 11(3):321-334. PubMed ID: 27609529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
    Swaminathan A; Borichevsky GM; Edwards TS; Hirschfeld E; Mules TC; Frampton CMA; Day AS; Hampton MB; Kettle AJ; Gearry RB
    J Crohns Colitis; 2022 Dec; 16(12):1862-1873. PubMed ID: 35803583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease.
    Bohra A; Batt N; Dutt K; Lewis D; Segal JP; Newiadomski O; Vasudevan A; Langenberg DRV
    Therap Adv Gastroenterol; 2024; 17():17562848241237895. PubMed ID: 38486818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
    Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell-activating factor (BAFF) in children with inflammatory bowel disease.
    Fodor I; Serban O; Serban DE; Farcau D; Man SC; Dumitrascu DL
    Pediatr Res; 2021 May; 89(7):1798-1803. PubMed ID: 32937648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
    Aomatsu T; Imaeda H; Matsumoto K; Kimura E; Yoden A; Tamai H; Fujiyama Y; Mizoguchi E; Andoh A
    Aliment Pharmacol Ther; 2011 Oct; 34(8):941-8. PubMed ID: 21848856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.